Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens

Documenti analoghi

• SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
  di: Hadeel T. Zedan, et al.
  Pubblicazione: (2024)
• Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
  di: Liu, Jia, et al.
  Pubblicazione: (2020)
• The controversy of SARS‐CoV‐2 integration into the human genome
  di: Laith AL‐Eitan, et al.
  Pubblicazione: (2024)
• Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
  di: Kuldeep Singh Patel
  Pubblicazione: (2020)
• Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
  di: Monica Rosas‐Lemus, et al.
  Pubblicazione: (2025)